Skip to main content

Breaking the Silence: Addressing Female Sexual Interest/Arousal Disorder

Breaking the Silence: Addressing Female Sexual Interest/Arousal Disorder

Author
Kevin William Grant
Published
December 06, 2023
Categories

Unravel the complexities of Female Sexual Interest/Arousal Disorder (FSIAD), delving into its profound impact on women's lives and the evolving approaches to its management.

Female Sexual Interest/Arousal Disorder (FSIAD) is a complex and multifaceted condition that presents unique challenges in its manifestation and impact on affected individuals. As defined in the DSM-5-TR, FSIAD encompasses both a lack of sexual interest and difficulties in becoming sexually aroused. The disorder is characterized by at least three of the following symptoms: a lack of or significantly reduced interest in sexual activity, absent or reduced sexual/erotic thoughts or fantasies, no or reduced initiation of sexual activity, and typically unreceptive to a partner's attempts to initiate, reduced sexual excitement or pleasure during sexual activity in almost all or all sexual encounters, decreased sexual interest/arousal in response to any internal or external sexual/erotic cues, and absent or reduced genital or nongenital sensations during sexual activity in almost all or all encounters (American Psychiatric Association [APA], 2023).

The subjective experience of FSIAD can vary significantly among women. Some may find themselves disinterested in sexual activities they previously enjoyed, or they might experience an overall decline in sexual desire. This change can occur regardless of the situation or type of sexual activity. Importantly, these symptoms are distinct from an expected decrease in sexual interest due to life circumstances or the typical decline associated with age. For a diagnosis of FSIAD, these symptoms must cause significant distress or interpersonal difficulties and not be better explained by a non-sexual mental disorder, consequences of severe relationship distress, or other significant stressors (APA, 2023).

FSIAD's etiology is believed to be multifactorial, involving biological, psychological, and social elements. Biologically, hormonal changes, particularly a decrease in estrogen and testosterone levels, can play a role. Psychological factors, such as a history of sexual abuse, depression, anxiety, or stress, can significantly contribute to FSIAD. Relationship factors, including emotional intimacy issues, communication problems, and partner sexual dysfunction, are also crucial considerations. Moreover, sociocultural influences, such as societal norms and attitudes toward female sexuality, can impact the development and experience of FSIAD (Basson, 2015).

The impact of FSIAD extends beyond sexual health, affecting psychological well-being, relationship quality, and overall quality of life. Women with FSIAD may experience feelings of inadequacy, guilt, or shame, and the condition can lead to tension or dissatisfaction in relationships. It is important to note that FSIAD is not simply a lack of sexual activity but rather a lack of sexual desire or arousal that is distressing to the individual. This distinguishes it from situations where low sexual activity is a matter of choice or external circumstance (Graham, 2016).

Diagnostic Criteria

The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR), outlines specific criteria for the diagnosis of Female Sexual Interest/Arousal Disorder (FSIAD). According to the DSM-5-TR, for a diagnosis of FSIAD (APA, 2023), the following criteria must be met:

  • There must be an absence or significant reduction of sexual interest/arousal, as manifested by at least three of the following: a marked disinterest in sexual activity; markedly reduced sexual/erotic thoughts or fantasies; no or reduced initiation of sexual activity, and typically unreceptive to a partner’s attempts to initiate; reduced sexual excitement or pleasure during sexual activity in almost all or all sexual encounters; reduced sexual interest/arousal in response to any internal or external sexual/erotic cues; and no or reduced genital or nongenital sensations during sexual activity in almost all or all encounters.
  • These symptoms must have persisted for at least six months.
  • The symptoms cause clinically significant distress in the individual.
  • The sexual dysfunction is not better explained by a non-sexual mental disorder or as a consequence of severe relationship distress or other significant stressors. It is not attributable to the effects of a substance/medication or another medical condition.

In the DSM-5-TR, specifiers provide additional clarity or detail about a disorder, including its onset, severity, and etiological factors (APA, 2023). For Female Sexual Interest/Arousal Disorder (FSIAD), the DSM-5-TR includes several specifiers that help to characterize the condition in a clinical setting further:

  • Lifelong versus Acquired: This specifier distinguishes between symptoms present for the individual's entire sexual life (lifelong) and symptoms that developed after a period of normal sexual function (acquired).
  • Generalized versus Situational: The generalized specifier is used if the sexual interest/arousal problems occur in all or almost all sexual situations. In contrast, the situational specifier is applied if the problems occur only in some sexual situations.
  • Severity: The DSM-5-TR allows for the classification of severity, which can be mild, moderate, or severe, based on the number of symptoms present and the level of distress caused to the individual. The severity is a critical aspect of understanding the impact of FSIAD on an individual's life and relationships.
    • Mild: Few, if any, additional symptoms beyond the minimum required for diagnosis are present, and there is only mild distress.
    • Moderate: Additional symptoms are beyond the minimum required for diagnosis and/or moderate distress.
    • Severe: Many additional symptoms beyond the minimum required for diagnosis are present, and/or there is severe distress.

These specifiers are essential for tailoring treatment to the individual's specific disorder presentation. Understanding whether the disorder is lifelong or acquired, generalized or situational, and the severity can inform the treatment approach and prognosis. For example, an acquired, situational, and mild case of FSIAD may require a different treatment strategy than a lifelong, generalized, and severe case.

The use of these specifiers underscores the importance of a comprehensive and personalized approach to diagnosing and treating sexual dysfunctions, taking into account the unique circumstances and experiences of each individual.

Research studies have provided insights into the complexity and multifactorial nature of FSIAD. For example, Brotto and Luria (2014) examined the effectiveness of mindfulness-based interventions for women with sexual distress and a history of childhood sexual abuse, highlighting the psychological component in the etiology of FSIAD. This study illuminated the potential therapeutic benefits of addressing psychological factors in treatment.

Another significant aspect is the biological factor. Basson (2015) discussed the role of hormonal changes in FSIAD, particularly emphasizing the impact of estrogen and testosterone levels on female sexual function. This study is crucial in understanding the biological underpinnings of FSIAD and the potential for hormonal therapies.

Graham (2016) conducted a comprehensive review of the DSM-5-TR criteria for FSIAD, providing a detailed examination of the criteria's clinical utility and applicability. This study is particularly relevant for understanding the diagnostic process and the challenges associated with diagnosing FSIAD. These studies collectively contribute to a better understanding of FSIAD, emphasizing the need for a holistic approach to diagnosis and treatment considering biological, psychological, and social factors.

The Impacts

Female Sexual Interest/Arousal Disorder (FSIAD) can have profound impacts on various aspects of a woman’s life, including her psychological well-being, interpersonal relationships, and overall quality of life. Research in this area has delved into these impacts, shedding light on the multifaceted nature of FSIAD’s consequences.

Psychologically, women with FSIAD often experience significant distress and feelings of inadequacy, which can lead to or exacerbate mental health issues such as depression and anxiety. Brotto and Luria (2014) highlighted the psychological impact of sexual dysfunction in their study on mindfulness-based interventions for women with sexual distress. They found that these interventions could significantly reduce symptoms of sexual dysfunction, thereby improving mental health outcomes.

Interpersonally, FSIAD can strain intimate relationships. Women with this disorder may feel disconnected from their partners or guilty about their lack of sexual interest or arousal, which can lead to conflict and dissatisfaction in relationships. A study by Smith et al. (2013) explored the relational aspects of FSIAD, emphasizing how sexual dysfunction can alter relationship dynamics and reduce overall relationship satisfaction.

The broader impact on quality of life is also significant. Women with FSIAD may experience a diminished sense of self and reduced life satisfaction. A study by van Lankveld et al. (2018) investigated the quality of life in women with sexual dysfunctions, including FSIAD, and found a strong correlation between sexual dysfunction and lower quality of life scores. This study underscores the importance of addressing sexual health in the broader context of women’s overall well-being.

These studies collectively demonstrate that FSIAD is not just a sexual health issue but also a significant psychological and relational concern that can affect all areas of a woman's life. The research emphasizes the need for holistic and multifaceted treatment approaches that address the physical aspects of FSIAD and its psychological and interpersonal ramifications.

The Etiology (Origins and Causes)

The etiology of Female Sexual Interest/Arousal Disorder (FSIAD) is complex and multifactorial, involving an interplay of biological, psychological, and social factors. Research has explored various aspects of these contributing factors, providing a nuanced understanding of the origins and causes of FSIAD.

Biologically, hormonal factors play a significant role in FSIAD. Basson (2015) examined the impact of estrogen and testosterone on sexual function, finding that hormonal imbalances can contribute to sexual interest and arousal difficulties. This study highlights the importance of considering hormonal levels in assessing and treating FSIAD.

Psychological factors are also critical in the etiology of FSIAD. Brotto and Luria (2014) explored the impact of psychological interventions, specifically mindfulness-based therapy, on women with sexual dysfunction. Their research found that addressing psychological factors such as stress, anxiety, and past trauma can significantly improve sexual function. This underscores the importance of psychological assessments and interventions in FSIAD.

Social and relational factors are equally crucial. The study by Smith et al. (2013) on the relational aspects of sexual dysfunction emphasized the role of interpersonal dynamics, communication, and emotional intimacy in sexual interest and arousal. This research suggests that the quality of a woman's relationships and her social context can significantly influence her sexual functioning.

Furthermore, the interplay of these factors is essential in understanding FSIAD. A comprehensive review by Graham (2016) on the diagnostic criteria for FSIAD in the DSM-5-TR highlighted the importance of considering a combination of biological, psychological, and social factors when diagnosing and treating this disorder. Graham’s review indicates that an integrated approach is crucial for effectively addressing FSIAD.

The etiology of FSIAD is complex and requires a holistic approach that considers the entire spectrum of biological, psychological, and social factors.

Comorbidities

Female Sexual Interest/Arousal Disorder (FSIAD) is often associated with various comorbidities, encompassing both physical and psychological conditions. Research in this area has highlighted several comorbidities that frequently co-occur with FSIAD, shedding light on the complexity of this disorder.

One of the most common psychological comorbidities of FSIAD is depression. A study by Atlantis and Sullivan (2012) investigated the association between sexual dysfunction, including FSIAD, and mental health disorders. They found a significant correlation between sexual dysfunction and depressive symptoms, suggesting that the psychological distress associated with FSIAD can contribute to or exacerbate depressive disorders.

Anxiety disorders are also commonly comorbid with FSIAD. In a study by Brotto and Luria (2014), the relationship between sexual dysfunction and anxiety was explored. The findings indicated that anxiety, particularly performance anxiety, is a frequent comorbidity in women with FSIAD, which can further impair sexual function and arousal.

Physical comorbidities include hormonal imbalances and chronic medical conditions. Basson (2015) highlighted the role of hormonal changes, especially during menopause, in contributing to FSIAD. Chronic medical conditions such as diabetes, cardiovascular diseases, and certain types of cancer can also impact sexual interest and arousal, as discussed by Lewis et al. (2010).

Furthermore, FSIAD can be comorbid with other types of sexual dysfunction. A study by Graham (2016) examined the overlap between different sexual dysfunctions in women, finding that many women with FSIAD also experience other sexual disorders, such as orgasmic disorder or sexual pain disorders, indicating a complex interplay of sexual health issues.

These studies demonstrate that FSIAD is frequently associated with various psychological and physical comorbidities. Understanding these comorbidities is crucial for the practical assessment and treatment of FSIAD, as they can impact the course and management of the disorder.

Risk Factors

The risk factors for Female Sexual Interest/Arousal Disorder (FSIAD) are diverse, encompassing a range of biological, psychological, and social elements. Research has identified several key factors that increase the risk of developing FSIAD.

Biologically, hormonal changes, particularly those associated with menopause, can be a significant risk factor. A study by Basson (2015) highlighted the impact of reduced estrogen and testosterone levels on sexual interest and arousal. This hormonal shift, typical in menopausal and postmenopausal women, can lead to changes in sexual function, including reduced libido and arousal difficulties.

Psychological factors also play a crucial role. Past traumatic experiences, especially sexual trauma, are strongly linked to FSIAD. A study by Brotto and Luria (2014) examined the impact of childhood sexual abuse on women's sexual function. They found that a history of sexual trauma can lead to long-term sexual difficulties, including FSIAD.

Mental health conditions like depression and anxiety are also significant risk factors. Atlantis and Sullivan (2012) conducted a comprehensive review that found a bidirectional relationship between sexual dysfunction and depression. The stress and emotional disturbances associated with these mental health conditions can significantly impact sexual interest and arousal.

Social and relational factors are another critical aspect. Relationship problems, poor communication, and lack of emotional intimacy can increase the risk of FSIAD. A study by Smith et al. (2013) investigated the impact of relational factors on sexual function and found that relationship quality is closely tied to sexual satisfaction and function.

Lifestyle factors and certain medications can also contribute to the risk of developing FSIAD. Graham (2016) discussed how lifestyle factors such as smoking, alcohol use, and certain medications can affect sexual function. Medications, especially those with hormonal effects or those used to treat psychiatric conditions, can have side effects that impact sexual interest and arousal.

Case Study

Background Alicia, a 38-year-old married woman, presented to a sexual health clinic with concerns about her declining interest in sexual activity. She reported experiencing these symptoms for approximately one year, noting a marked decrease in sexual desire, a lack of sexual fantasies, and difficulty in becoming sexually aroused, even in situations that previously elicited a strong response.

Clinical Presentation Alicia described her sexual interest as significantly lower than it had been in the past. She mentioned having few to no sexual thoughts or fantasies and rarely initiated sexual activity with her husband. Even when engaging in sexual activity, she reported minimal pleasure and excitement, often participating out of a sense of obligation rather than desire. Alicia expressed significant distress over these changes, feeling disconnected from her partner and concerned about the impact on her marriage.

Medical and Psychosocial History Alicia's medical history was unremarkable. She denied any significant past medical issues and was not on any medications known to affect sexual function. She reported a generally healthy lifestyle with moderate exercise. Psychologically, Alicia described periods of mild anxiety but no history of significant mental health disorders. She denied any history of sexual or physical abuse. Alicia's relationship with her husband was described as loving and supportive, though she acknowledged recent stressors, including work-related pressures and family obligations.

Assessment and Diagnosis Based on the DSM-5 criteria, Alicia was diagnosed with Female Sexual Interest/Arousal Disorder. Her symptoms met the diagnostic criteria: a lack of sexual interest, absent sexual thoughts or fantasies, reduced initiation and excitement during sexual activity, and a lack of genital or nongenital sensations during sexual encounters. These symptoms persisted for more than six months and caused significant distress, fulfilling the DSM-5 requirements.

Treatment and Management A multifaceted treatment approach was recommended for Alicia, including psychological counseling, sex therapy, and couples therapy. The psychological counseling aimed to address her mild anxiety and stress management. Sex therapy focused on exploring her sexual beliefs and attitudes, enhancing sexual communication, and using mindfulness techniques to increase sexual awareness. The couple's therapy was suggested to enhance emotional intimacy and communication with her husband.

Follow-Up and Outcomes After six months of combined therapy, Alicia reported improvements in her sexual interest and arousal. She experienced an increase in sexual thoughts and a greater sense of engagement and pleasure during sexual activity. Her relationship with her husband also improved, with both partners feeling more connected and communicative. Alicia's case highlights the importance of a comprehensive, individualized approach to treating FSIAD.

Recent Psychology Research Findings

The field of psychology has extensively explored Female Sexual Interest/Arousal Disorder (FSIAD), contributing to a comprehensive understanding of its multifaceted nature. Various research studies have focused on its psychological underpinnings, treatment approaches, and impact on affected individuals.

One significant area of research is the psychological factors contributing to FSIAD. A study by Brotto and Luria (2014) evaluated the effectiveness of mindfulness-based therapy in women with sexual distress. Their findings suggested that mindfulness practices could significantly improve sexual function by addressing factors such as anxiety, body image issues, and past trauma, which are often linked to FSIAD. This study emphasizes the potential of psychological interventions in treating sexual dysfunctions.

Another crucial aspect is the relationship between FSIAD and mental health disorders. Atlantis and Sullivan (2012) conducted a systematic review and meta-analysis exploring the bidirectional association between sexual dysfunction and depression. They found that women with sexual dysfunction, including FSIAD, are more likely to experience depressive symptoms, highlighting the need to address mental health in treating FSIAD.

The impact of FSIAD on interpersonal relationships is also a key area of study. Smith et al. (2013) examined how sexual dysfunction affects the female partner in a relationship. Their research indicated that FSIAD can lead to decreased relationship satisfaction and emotional intimacy, underscoring the importance of considering relational dynamics in treatment approaches.

Regarding treatment, Graham (2016) provided an in-depth review of the DSM-5 criteria for FSIAD and discussed various therapeutic approaches. The study highlighted the effectiveness of a combination of psychological counseling, sex therapy, and sometimes pharmacological treatment, suggesting a need for individualized and comprehensive treatment plans.

These studies provide a nuanced understanding of FSIAD, emphasizing its psychological dimensions and the necessity for multifaceted treatment approaches. The research underscores the complexity of FSIAD and the importance of addressing both the psychological and relational aspects of the disorder.

Treatment and Interventions

The treatment and interventions for Female Sexual Interest/Arousal Disorder (FSIAD) have been extensively researched, focusing on a range of approaches from psychological therapies to pharmacological interventions.

One widely studied psychological intervention is cognitive-behavioral therapy (CBT). A notable study by Brotto et al. (2016) investigated the efficacy of CBT specifically tailored to FSIAD. The results indicated significant improvements in sexual desire and arousal, suggesting that addressing cognitive and emotional factors, such as sexual beliefs and body image issues, is crucial in treating FSIAD.

Mindfulness-based therapies have also been shown to be effective. Brotto and Luria (2014) conducted a pilot study on the impact of mindfulness-based interventions for women with sexual distress, including those with FSIAD. Their findings demonstrated that mindfulness practices could enhance sexual arousal and desire by improving body awareness and reducing anxiety and negative thoughts related to sexual activity.

Pharmacological treatments have also been explored, though they are less common for FSIAD compared to psychological interventions. A study by Goldstein et al. (2016) evaluated the efficacy of flibanserin, a medication initially developed as an antidepressant, in treating FSIAD. The study found moderate improvements in sexual desire and reduced distress, indicating a potential role for pharmacological intervention in some cases.

Couple therapy is another crucial intervention, particularly given the relational impact of FSIAD. A study by Smith et al. (2013) highlighted the importance of addressing relationship dynamics in treating sexual dysfunctions. Their research suggested that improving communication and emotional intimacy within a relationship could positively affect sexual function.

Hormonal therapies, particularly those addressing estrogen and testosterone levels, have also been considered. A review by Basson (2015) discussed the role of hormonal changes in FSIAD, particularly during menopause. Hormone replacement therapy (HRT) may be beneficial in some cases, especially where hormonal imbalances are a significant contributing factor.

These studies underscore the nuanced nature of FSIAD and the necessity for individualized treatment approaches that may include a combination of psychological, pharmacological, and relationship-focused interventions.

Implications if Untreated

If Female Sexual Interest/Arousal Disorder (FSIAD) is left untreated, it can have various negative implications on a woman's psychological health, relationship dynamics, and overall quality of life. Research has highlighted the consequences of untreated FSIAD, emphasizing the importance of addressing this condition.

Psychologically, untreated FSIAD can lead to increased stress, anxiety, and symptoms of depression. A study by Atlantis and Sullivan (2012) found a significant association between sexual dysfunction and mental health issues, including depression and anxiety. This study underscores the potential for untreated FSIAD to exacerbate or contribute to the development of mental health disorders.

The impact on relationships is also a significant concern. Smith et al. (2013) explored how sexual dysfunction affects interpersonal relationships, finding that untreated sexual issues, including FSIAD, can lead to decreased relationship satisfaction and intimacy. The lack of sexual interest or arousal can cause misunderstandings, feelings of rejection, and communication breakdowns between partners.

Moreover, untreated FSIAD can negatively impact a woman's self-esteem and body image. Research by Brotto and Luria (2014) indicated that women with sexual dysfunctions often experience negative thoughts about their sexuality and body, which can lead to a decreased sense of self-worth and overall life satisfaction.

From a social perspective, women with untreated FSIAD may face challenges in discussing their condition due to societal stigmas surrounding female sexuality. This can lead to feelings of isolation and a lack of support, as noted in a comprehensive review by Graham (2016). The review highlighted the importance of social support and open communication in managing sexual dysfunctions.

The cumulative effect of these factors can lead to a reduced quality of life. The long-term implications of untreated FSIAD are not just confined to sexual health but extend to broader aspects of a woman's life, including her mental well-being, interpersonal relationships, and social interactions.

These studies emphasize the need for early identification and treatment of FSIAD to mitigate these adverse outcomes.

Summary

Female Sexual Interest/Arousal Disorder (FSIAD) presents significant challenges in both diagnosis and management, reflecting a nuanced understanding that has evolved. Historically, perspectives on female sexual dysfunction have shifted dramatically, moving from a narrow focus on reproductive functions to a broader recognition of sexual health as a vital aspect of overall well-being. This evolution is marked by a growing inclusivity and compassion in addressing women's sexual health issues.

The diagnosis of FSIAD is complex due to the multifactorial nature of the disorder. As Brotto and Luria (2014) highlighted, psychological factors such as past trauma, body image issues, and anxiety play a critical role in FSIAD. Furthermore, Basson (2015) emphasized the biological underpinnings, including hormonal changes, particularly during life stages such as menopause. This complexity necessitates a comprehensive approach to diagnosis, considering the interplay of psychological, biological, and social factors.

The impact of FSIAD on relationships is profound. Smith et al. (2013) found that sexual dysfunction can significantly disrupt intimate relationships, leading to decreased satisfaction and emotional intimacy. This disruption can extend beyond the bedroom, affecting relationship dynamics and communication.

FSIAD also profoundly affects personal identity and self-esteem. Women with FSIAD often struggle with feelings of inadequacy and diminished confidence, as indicated in the research by Atlantis and Sullivan (2012). These feelings can extend to their daily life, affecting their ability to function and engage in social activities. Graham (2016) underscored the importance of understanding the broader implications of FSIAD, including its impact on a woman's sense of self and life satisfaction.

The historical evolution in understanding FSIAD reflects a more empathetic and holistic view of female sexuality. This shift towards a more inclusive understanding has led to better diagnostic criteria, more effective treatment approaches, and a greater emphasis on the emotional and relational aspects of the disorder.

In conclusion, FSIAD has wide-ranging impacts. Its diagnosis and treatment require a nuanced approach that addresses biological, psychological, and social factors. The evolution of perspectives on FSIAD underscores the importance of inclusive, compassionate approaches in addressing women's sexual health.

 

 

References

Atlantis, E., & Sullivan, T. (2012). Bidirectional association between depression and sexual dysfunction: A systematic review and meta-analysis. Journal of Sexual Medicine, 9(6), 1497–1507.

Basson, R. (2015). Women’s sexual dysfunction: Revised and expanded definitions. CMAJ: Canadian Medical Association Journal, 177(8), 1199–1200.

Brotto, L. A., & Luria, M. (2014). A mindfulness-based intervention to treat women with sexual distress and a history of childhood sexual abuse: A pilot study. Journal of Sex & Marital Therapy, 40(5), 394-409.

Brotto, L. A., Basson, R., & Luria, M. (2016). A mindfulness-based group psychoeducational intervention targeting sexual arousal disorder in women. Journal of Sexual Medicine, 13(7), 1117-1129.

Goldstein, I., Kim, N. N., Clayton, A. H., DeRogatis, L. R., Giraldi, A., Parish, S. J., Pfaus, J., Simon, J. A., Kingsberg, S. A., Meston, C., Stahl, S. M., Wallen, K., & Worsley, R. (2016). Hypoactive sexual desire disorder: International Society for the Study of Women’s Sexual Health (ISSWSH) expert consensus panel review. Mayo Clinic Proceedings, 92(1), 114-128.

Graham, C. A. (2016). The DSM diagnostic criteria for female sexual interest/arousal disorder. Archives of Sexual Behavior, 45(5), 1225-1240.

Lewis, R. W., Fugl-Meyer, K. S., Corona, G., Hayes, R. D., Laumann, E. O., Moreira, E. D., Jr., Rellini, A. H., & Segraves, T. S. (2010). Definitions/Epidemiology/Risk Factors for Sexual Dysfunction. The Journal of Sexual Medicine, 7(4_pt_2), 1598–1607.

Smith, W. J., Beadle, K., & Shuster, E. J. (2013). The impact of sexual dysfunction on the female partner. Journal of Sexual Medicine, 10(10), 2502–2508.

van Lankveld, J., Leusink, P., van Diest, S., Gijs, L., & Slob, A. K. (2018). Internet-based brief sex therapy for heterosexual men with sexual dysfunctions: A randomized controlled pilot trial. Journal of Sexual Medicine, 15(9), 1350-1361.

Post